RAIN
Income statement / Annual
Last year (2023), Rain Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Rain Therapeutics Inc.'s net income was -$437,007.00.
See Rain Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$61.40 M
|
$40.77 M
|
$15.37 M
|
$7.29 M
|
| General & Administrative Expenses |
$409,848.00
|
$15.74 M
|
$10.74 M
|
$3.59 M
|
$3.54 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$409,848.00
|
$15.74 M
|
$10.74 M
|
$3.59 M
|
$3.54 M
|
| Other Expenses |
$225.00
|
$0.00
|
$1,000.00
|
-$2.02 M
|
-$251,000.00
|
| Operating Expenses |
$410,073.00
|
$77.14 M
|
$51.51 M
|
$18.96 M
|
$10.83 M
|
| Cost And Expenses |
$410,073.00
|
$77.14 M
|
$51.51 M
|
$18.96 M
|
$10.83 M
|
| Interest Income |
$107.00
|
$1.42 M
|
$119,000.00
|
$32,000.00
|
$209,000.00
|
| Interest Expense |
$27,041.00
|
$0.00
|
$0.00
|
$135,000.00
|
$32,000.00
|
| Depreciation & Amortization |
$12,648.00
|
$80,000.00
|
$120,000.00
|
-$1.94 M
|
-$14,000.00
|
| EBITDA |
-$397,318.00 |
-$77.06 M |
-$51.51 M |
-$18.91 M |
-$10.84 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$26,934.00
|
$1.42 M
|
$120,000.00
|
-$2.13 M
|
-$74,000.00
|
| Income Before Tax |
-$437,007.00
|
-$75.72 M
|
-$51.39 M
|
-$21.08 M
|
-$10.90 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$3,000.00
|
$2,000.00
|
-$1.89 M
|
-$219,000.00
|
| Net Income |
-$437,007.00
|
-$75.72 M
|
-$51.39 M
|
-$19.20 M
|
-$10.68 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.0637 |
-16.26 |
-15.9 |
-10.8 |
-26.52 |
| EPS Diluted |
-0.0637 |
-16.26 |
-15.9 |
-10.8 |
-26.52 |
| Weighted Average Shares Out |
$6.86 M
|
$4.66 M
|
$3.23 M
|
$1.78 M
|
$403,000.01
|
| Weighted Average Shares Out Diluted |
$6.86 M
|
$4.66 M
|
$3.23 M
|
$1.78 M
|
$403,162.84
|
| Link |
|
|
|
|
|
